Trusted for Being Honest
I’d rather be trusted for being honest than respected for being impressive.
I — The sentence
In March I wrote a short piece about my research and why I was giving it away. Near the end, under a heading I called “The Honest Part,” I wrote that one line. It is on my About page[dead link] now too. I want to say what it means, because a sentence like that is easy to write and harder to keep.
II — Impressive is the easy direction
Every inventor feels the pull. You make the claim a little bigger than the evidence. You leave out the part that did not work. You let a reader assume something you never said.
The same month, in another essay, I wrote that the inventor community has a culture of fake confidence. Act like you’re already a billionaire. Never admit you’re struggling. I said I was tired of pretending.
Trust works the other way. It is slow. It comes from saying the smaller true thing and letting it stand.
III — Saying what a thing is not
The first habit is plain. Say what the thing is. Then say what it is not.
A blueprint in my catalog is the design document for an invention. It is not the physical product. It is not the IP. It is not a partnership. When you buy, you buy the use of that blueprint only. I wrote that down where anyone can read it.
I do the same with patent-pending. I have written down what those two words do not mean. They do not mean a patent has issued. They do not mean an examiner has decided anything. They do not mean I can sue anyone today. I am not taking any of that back.
On the question of whether my chip work is quantum, I wrote down what is quantum and what is classical, so that no one is scammed and no one is lost. And when a thing is a design, I call it a design.
IV — Writing down the limits
The medical research is where this matters most. I am not a doctor. I am not a pharmaceutical scientist. I am an inventor who built a computational tool, Alchemy Data V2, and applied it to disease research. It finds overlaps between what compounds are made of and what disease mechanisms involve. Those overlaps generate hypotheses. A hypothesis is a place to start looking. It is not a result.
Every research package I released carried a safety disclaimer, a methodology document, and an honest assessment of the evidence. In the Alzheimer’s and Parkinson’s reports, the grading separates two questions: is an element involved in the disease, and does targeting it actually help? In most cases the first came out high and the second came out low or unproven. I published both.
In the largest package, most of the results had not yet been checked against published databases. The status file inside it said so. If I had left that out, the package would have looked bigger. It would also have been less true.
Back then I put it this way: “We’d rather lose credibility by being too cautious than gain attention by being too optimistic.”
V — Correcting myself
The hardest part is going back. The V3 Known Properties Reports correct earlier versions that were too optimistic. In the Parkinson’s analysis, one compound had the strongest published clinical evidence of any in the set. I still lowered its grade from A to B+, because the study behind it was small and open-label, with no placebo group. Being honest about evidence quality is more important than being optimistic.
The Alzheimer’s report named the trials that failed. The Parkinson’s package carried the promising leads, the failures, and the safety warnings together. A research file that shows only the promising leads is a brochure.
I wrote in The Wheel that working is not the finish line. Better is. A correction is just better, written down.
VI — Letting the work speak
The same goes for the tools I use. I have written that there is no reason to trust AI. I used it anyway. I checked it. I corrected it when it was wrong, which was often. I kept what was right. I held the line on what was real and what was wishful. What I asked of the reader was simple: verify the work, not the tool. Take it apart. If it holds, it holds.
That is the deal with everything I put out. I will tell you what a thing is. I will tell you what it is not. I will tell you where the evidence is thin and where an earlier version went too far. Then the work has to stand on its own.
VII — Why trust
Respect for being impressive lasts until somebody checks. Trust for being honest is what is left after they do.
I would rather build the second kind. It is smaller at first. It does not make a headline. But a reader who finds that I told the truth about the limits has a reason to take the rest seriously. A reader who finds that I hid something has no reason to believe any of it.
So the sentence stays on the About page. And it stays in how I write everything else.
--- ## Sources (every factual claim, his own published pages) 1. The line, written in March under "The Honest Part" near the end of the research essay; the essay is about the research and why he gave it away. — D:\special\crione-static\site-essays\essays\about-christopher-gabriel-brown-research\index.html (dated Mar 21, 2026) 2. The line also appears on the About page (curly apostrophe, as used here). — D:\special\crione-static\site-about\about\index.html 3. Same month (Mar 25, 2026): "The inventor community has this culture of fake confidence — act like you're already a billionaire ... never admit that you're struggling"; "I'm tired of pretending." — D:\special\crione-static\site-essays\essays\i-built-30-inventions-filed-1752-patents-and-havent-sold-a-single-one\index.html 4. A blueprint is the design document for the invention; not the physical product, not the IP, not a partnership. — D:\special\crione-static\site-essays\essays\what-we-sell\index.html 5. "When you buy, you buy the use of that blueprint only." — D:\special\crione-static\site-about\about\index.html 6. What patent-pending does not mean (no patent issued, no examiner decision, cannot sue anyone today); "I am not taking any of that back." — D:\special\crione-static\site-essays\essays\this-cannot-be-replicated\index.html 7. "We distinguished what is quantum and what is classical. We wrote it down so that no one is scammed and no one is lost." The question itself is an essay title ("Is This Quantum?"). — D:\special\crione-static\site-essays\essays\no-scam-clarity-quantum\index.html; quantum-vs-classical-what-we-build\index.html; is-this-quantum-how-chips-are-made\index.html 8. "These are designs, and I call them designs." — D:\special\crione-static\site-essays\essays\this-cannot-be-replicated\index.html 9. Not a doctor / not a pharmaceutical scientist / inventor who built a computational tool and applied it to disease research; Alchemy Data V2; overlaps between what compounds are made of and what disease mechanisms involve generate hypotheses. — about-christopher-gabriel-brown-research\index.html and D:\special\crione-static\site-about\about\index.html 10. Every one of the research packages included SAFETY_DISCLAIMER.md, METHODOLOGY.md and honest evidence assessments; Alzheimer's/Parkinson's V3 grading separates pathological relevance (is the element involved) from therapeutic relevance (does targeting it help); "in most cases" high vs low/unproven. — D:\special\crione-static\site-essays\essays\safety-disclaimer-research-responsibility\index.html 11. Largest package (300 diseases): most results not yet cross-referenced with published databases; the STATUS.md file documents this. — D:\special\crione-static\site-essays\essays\300-disease-database-overview\index.html 12. "We'd rather lose credibility by being too cautious than gain attention by being too optimistic." — safety-disclaimer-research-responsibility\index.html (Mar 18, 2026) 13. "The V3 Known Properties Reports correct earlier versions that were too optimistic." — about-christopher-gabriel-brown-research\index.html; alzheimers-metal-amino-acid-honest-assessment\index.html 14. Parkinson's analysis: one compound had the strongest published clinical evidence of all compounds analysed; downgraded from A to B+ (open-label, no placebo group, small sample); "Being honest about evidence quality is more important than being optimistic." — D:\special\crione-static\site-essays\essays\nac-parkinsons-monti-2019-evidence\index.html 15. Alzheimer's V3 report lists the metal-targeting trials that failed; the Parkinson's package includes "the promising leads, the failures, and the safety warnings." — alzheimers-metal-amino-acid-honest-assessment\index.html; nac-parkinsons-monti-2019-evidence\index.html 16. "Working is not the finish line. Better is." — D:\special\crione-static\site-essays\essays\the-wheel\index.html; restated in this-cannot-be-replicated\index.html 17. "There is no reason to trust artificial intelligence"; "I held the line on what was real and what was wishful"; "I used them. I checked them. I corrected them when they were wrong, which was often. I kept what was right."; "Verify the work, not the tool"; "Take it apart. If it holds, it holds." — D:\special\crione-static\site-essays\essays\no-reason-to-trust\index.html